Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2006
05/04/2006US20060094747 Substituted carboxylic acids
05/04/2006US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma
05/04/2006US20060094743 Isoquinoline compounds and medicinal use thereof
05/04/2006US20060094741 Remedies for neuropathic pain and model animals of neuropathic pain
05/04/2006US20060094740 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
05/04/2006US20060094717 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
05/04/2006US20060094716 1-Pyridin-4-yl-urea derivatives
05/04/2006US20060094714 Compounds and their use to treat diabetes and related disorders
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006CA2586738A1 (2-carboxamido)(3-amino) thiophene compounds
05/04/2006CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
05/03/2006EP1651648A2 Compounds and compositions as protein kinase inhibitors
05/03/2006EP1651647A1 Nicotinamide derivatives useful as pdea4 inhibitors
05/03/2006EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors
05/03/2006EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors
05/03/2006EP1651631A1 Bicyclic imidazol derivatives against flaviviridae
05/03/2006EP1651626A1 Urea derivatives and their use as tyrosinkinase inhibitors
05/03/2006EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/03/2006EP1651602A2 Aryl heteroaromatic products, compositions comprising the same and use thereof
05/03/2006EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
05/03/2006EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
05/03/2006EP1499624A4 Electroluminescent materials
05/03/2006EP1368006B1 Novel modified released formulation
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
05/03/2006EP0937069B1 Piperazino derivatives as neurokinin antagonists
05/03/2006CN1768059A Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
05/03/2006CN1768058A Imidazopyridine derivatives as melanocortin receptor agonists.
05/03/2006CN1768055A 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
05/03/2006CN1768051A Substituted pyrazoles
05/03/2006CN1768041A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
05/03/2006CN1768026A 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
05/03/2006CN1765899A Diazabicyclic central nervous system active agents
05/03/2006CN1254476C Dihydroimidazo[5,1-a]-beta-carboline derivatives, method for preparing same and use thereof as medicine
05/03/2006CN1254475C 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists
05/03/2006CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
05/02/2006US7038054 Libraries; drug design
05/02/2006US7038053 Process for imidazo[4,5-c]pyridin-4-amines
05/02/2006US7038051 Imidazonaphthyridines
05/02/2006US7038048 Compositions for treatment of cell proliferation disorders
05/02/2006US7037923 MAP p38 kinase inhibitors; antiarthritic, antiinflammatory, antiischemic, and anticarcinogenic agents; reperfusion injuries; autoimmune and carciovascular diseases
05/02/2006US7037922 tachykinin NK-3 receptor antagonists have potential utility in treatment of broad array of disorders and diseases of central nervous system and periphery in mammals in which activation of NK-3 receptors is of importance, such as anxiety, panic disorder, depression, schizophrenia
05/02/2006US7037915 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents
05/02/2006US7037913 Piperazinyl derivatives of naphthalenes, (iso)quinolines and naphthyridines; used particularly the treatment of HIV and AIDS.
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease
05/02/2006CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
04/2006
04/27/2006WO2006044573A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
04/27/2006WO2006044355A1 Triazoles and their use as bradykinin b1 receptor antagonists
04/27/2006WO2006044133A1 Active ketone inhibitors of tryptase
04/27/2006WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease
04/27/2006WO2006043090A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
04/27/2006WO2006043064A1 Piperidines and related compounds for treatment of alzheimer's disease
04/27/2006WO2006042599A1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors
04/27/2006WO2006028896A3 Chemical compounds
04/27/2006WO2005101989A3 Piperidine derivatives as modulators of chemokine receptor ccr5
04/27/2006US20060089496 inhibitors of trypsin-like serine proteases; anticoagulant agents to treat thromboembolic disorders
04/27/2006US20060089378 Tetrahydro-pyridinyl pyrazole cannabinoid modulators
04/27/2006US20060089377 Tenatoprazole salts and process of preparation thereof
04/27/2006US20060089376 Tenatoprazole salts and process of preparation thereof
04/27/2006US20060089375 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
04/27/2006US20060089372 Dihydroimidazo[5,1-a]sg(b)-carboline derivatives, method for preparing same and use thereof as medicine
04/27/2006US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity
04/27/2006US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics
04/27/2006CA2584651A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
04/27/2006CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease
04/27/2006CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
04/27/2006CA2584170A1 Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases
04/27/2006CA2584041A1 Biphenyl integrin antagonists
04/27/2006CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease
04/27/2006CA2583158A1 Triazoles and their use as bradykinin b1 receptor antagonists
04/26/2006EP1650208A1 White-emitting compounds, process for the production thereof, and white-emitting devices
04/26/2006EP1650206A1 Phenylazole compounds, production process, and antioxidants
04/26/2006EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives
04/26/2006EP1650189A1 Benzylamine derivative
04/26/2006EP1648921A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions
04/26/2006EP1648893A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
04/26/2006EP1648891A1 Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands
04/26/2006EP1648890A2 Aryl-condensed 3-arylpyridine compounds and use thereof for controlling pathogenic fungi
04/26/2006EP1648889A1 Isethionate salt of a selective cdk4 inhibitor
04/26/2006EP1648873A2 Neuroprotective macrocylic compounds and methods for their use
04/26/2006EP1648872A2 Aryl fused azapolycyclic compounds
04/26/2006EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
04/26/2006EP1648867A1 Ppar active compounds
04/26/2006EP1648864A1 Photochromic diarylethene-containing coordination compounds and the production thereof
04/26/2006EP1648463A2 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
04/26/2006EP1648455A2 Anaplastic lymphoma kinase modulators and methods of use
04/26/2006EP1648448A1 Chemical compounds
04/26/2006EP1648443A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
04/26/2006EP1409485B1 Immunomodulating compounds
04/26/2006EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
04/26/2006EP1309592B1 Substituted pyrazoles
04/26/2006CN1764665A Process for the production of imidazopyridin-8-ones.
04/26/2006CN1764662A Cyclic benzimidazoles.
04/26/2006CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors
04/26/2006CN1763047A Vinorelbine preparation method
04/26/2006CN1763039A Indolizine carboxyl acid analog compound synthesis method
04/26/2006CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same
04/26/2006CN1253454C Beta-carboline and thio-analogues subsitituted by amino-acid radical/acyl, preparing method and application thereof
04/26/2006CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines
04/26/2006CN1253452C Thioether subsituted imidazoquinoline compound
04/26/2006CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors